Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S

Various vaccines were developed to reduce the spread of the Severe Acute Respiratory Syndrome Cov-2 (SARS-CoV-2) virus. Quickly after the start of vaccination, reports emerged that anti-SARS-CoV-2 vaccines, including ChAdOx1-S, could be associated with an increased risk of thrombosis. We investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: de Laat, Bas, Stragier, Hendrik, de Laat-Kremers, Romy, Ninivaggi, Marisa, Mesotten, Dieter, Thiessen, Steven, Van Pelt, Kristien, Roest, Mark, Penders, Joris, Vanelderen, Pascal, Huskens, Dana, De Jongh, Raf, Laenen, Margot Vander, Fivez, Tom, ten Cate, Hugo, Heylen, Rene, Heylen, Line, Steensels, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372359/
https://www.ncbi.nlm.nih.gov/pubmed/35966540
http://dx.doi.org/10.3389/fcvm.2022.966028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372359/
https://www.ncbi.nlm.nih.gov/pubmed/35966540
http://dx.doi.org/10.3389/fcvm.2022.966028

Ejemplares similares